These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34985967)

  • 1. TRIB3 reduces CD8
    Shang S; Yang YW; Chen F; Yu L; Shen SH; Li K; Cui B; Lv XX; Zhang C; Yang C; Liu J; Yu JJ; Zhang XW; Li PP; Zhu ST; Zhang HZ; Hua F
    Sci Transl Med; 2022 Jan; 14(626):eabf0992. PubMed ID: 34985967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
    Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
    Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
    Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW
    Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
    Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
    J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
    Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B
    Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17 cells inhibit CD8
    Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
    J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
    EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
    Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
    J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL10 mediates CD8
    Yan W; Qiu L; Yang M; Xu A; Ma M; Yuan Q; Ma X; Liang W; Li X; Lu Y
    Cancer Lett; 2023 Jul; 567():216263. PubMed ID: 37354983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
    Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.
    Liu C; Zhang W; Wang J; Si T; Xing W
    Cancer Sci; 2021 Oct; 112(10):4198-4207. PubMed ID: 34375482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPS6 promotes tumor progression and reduces CD8
    Du WQ; Zhu ZM; Jiang X; Kang MJ; Pei DS
    Acta Pharmacol Sin; 2023 Sep; 44(9):1890-1905. PubMed ID: 37095198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
    Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
    Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trouble with TRIBbles: TRIB3 blocks CD8 T cell homing to colorectal cancers.
    Clark RA
    Sci Immunol; 2022 Feb; 7(68):eabo2990. PubMed ID: 35119938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.
    Miyoshi N; Ishii H; Mimori K; Takatsuno Y; Kim H; Hirose H; Sekimoto M; Doki Y; Mori M
    Br J Cancer; 2009 Nov; 101(10):1664-70. PubMed ID: 19904274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
    Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
    Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
    Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
    Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
    Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
    Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
    Mondal D; Mathur A; Chandra PK
    Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.